ACS Chemical Neuroscience · 2018 · 131 citations · 49 references
MedicineNeurologyNeuroscienceCognitive NeuroscienceDementiaNeurodegenerationAlzheimer DiseaseBrain ImagingCognitive ImpairmentMagnetic Resonance ImagingMagnetic SusceptibilityNeurodegenerative DisordersAlzheimer Disease DementiaGray Matter AnatomyMagnetic Resonance Imaging Iron QuantificationMagnetic Susceptibility MeasurementNeuroimaging MarkersNeuroimaging Of Cognitive ImpairmentQuantitative Susceptibility MappingStructural Magnetic Resonance Imaging Markers
The excessive accumulation of iron in deep gray structures is an important pathological characteristic in patients with Alzheimer's disease (AD). Quantitative susceptibility mapping (QSM) is more specific than other imaging-based iron measurement modalities and allows noninvasive assessment of tissue magnetic susceptibility, which has been shown to correlate well with brain iron levels. This study aimed to investigate the correlations between the magnetic susceptibility values of deep gray matter nuclei and the cognitive functions assessed by mini-mental state examination (MMSE) and Montreal cognitive assessment (MoCA) in patients with mild and moderate AD. Thirty subjects with mild and moderate AD and 30 age- and sex-matched healthy controls were scanned with a 3.0 T magnetic resonance imaging (MRI) scanner. The magnetic susceptibilities of the regions of interest (ROIs), including caudate nucleus (Cd), putamen (Pt), globus pallidus (Gp), thalamus (Th), red nucleus (Rn), substantia nigra (Sn), and dentate nucleus (Dn), were quantified by QSM. We found that the susceptibility values of the bilateral Cd and Pt were significantly higher in AD patients than the controls ( P < 0.05). In contrast, bilateral Rn had significantly lower susceptibility values in AD than the controls. Regardless of gender and age, the increase of magnetic susceptibility in the left Cd was significantly correlated with the decrease of MMSE scores and MoCA scores ( P < 0.05). Our study indicated that magnetic susceptibility value of left Cd could be potentially used as a biomarker of disease severity in mild and moderate AD.
49
Guy M. McKhann, David S. Knopman, Howard Chertkow et al. · Alzheimer s & Dementia · 2011 · 18.8K citations · Full text
Cerebral Blood Flow in Dementia
Vladimir Hachinski, L. D. Iliff, E. Zilhka et al. · Archives of Neurology · 1975 · 3.2K citations
Medicine, Neurology, Neuroscience +14
Copper, iron and zinc in Alzheimer's disease senile plaques
Mark A. Lovell, J. David Robertson, W.J. Teesdale et al. · Journal of the Neurological Sciences · 1998 · 2.1K citations
Susceptibility weighted imaging (SWI)
E. Mark Haacke, Yingbiao Xu, Yu‐Chung N. Cheng et al. · Magnetic Resonance in Medicine · 2004 · 1.6K citations